150 related articles for article (PubMed ID: 31383581)
1. ZEB2 in T-cells and T-ALL.
De Coninck S; Berx G; Taghon T; Van Vlierberghe P; Goossens S
Adv Biol Regul; 2019 Dec; 74():100639. PubMed ID: 31383581
[TBL] [Abstract][Full Text] [Related]
2. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
[TBL] [Abstract][Full Text] [Related]
3. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.
Wang J; Farkas C; Benyoucef A; Carmichael C; Haigh K; Wong N; Huylebroeck D; Stemmler MP; Brabletz S; Brabletz T; Nefzger CM; Goossens S; Berx G; Polo JM; Haigh JJ
PLoS Biol; 2021 Sep; 19(9):e3001394. PubMed ID: 34550965
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia.
Goossens S; Peirs S; Van Loocke W; Wang J; Takawy M; Matthijssens F; Sonderegger SE; Haigh K; Nguyen T; Vandamme N; Costa M; Carmichael C; Van Nieuwerburgh F; Deforce D; Kleifeld O; Curtis DJ; Berx G; Van Vlierberghe P; Haigh JJ
Blood; 2017 Feb; 129(8):981-990. PubMed ID: 28069602
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.
Wu C; Li J; Tian C; Shi W; Jiang H; Zhang Z; Wang H; Zhang Q; Sun W; Sun P; Xiang R; Yang S
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2511-2525. PubMed ID: 29778661
[TBL] [Abstract][Full Text] [Related]
6. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
[TBL] [Abstract][Full Text] [Related]
7. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract][Full Text] [Related]
8. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors.
Yalim-Camci I; Balcik-Ercin P; Cetin M; Odabas G; Tokay N; Sayan AE; Yagci T
Mol Carcinog; 2019 Jun; 58(6):1068-1081. PubMed ID: 30790340
[TBL] [Abstract][Full Text] [Related]
9. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
[TBL] [Abstract][Full Text] [Related]
10. Ezh2 loss propagates hypermethylation at T cell differentiation-regulating genes to promote leukemic transformation.
Wang C; Oshima M; Sato D; Matsui H; Kubota S; Aoyama K; Nakajima-Takagi Y; Koide S; Matsubayashi J; Mochizuki-Kashio M; Nakano-Yokomizo T; Bai J; Nagao T; Kanai A; Iwama A; Sashida G
J Clin Invest; 2018 Aug; 128(9):3872-3886. PubMed ID: 30080177
[TBL] [Abstract][Full Text] [Related]
11. The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy.
Yu S; Zhou X; Steinke FC; Liu C; Chen SC; Zagorodna O; Jing X; Yokota Y; Meyerholz DK; Mullighan CG; Knudson CM; Zhao DM; Xue HH
Immunity; 2012 Nov; 37(5):813-26. PubMed ID: 23103132
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia.
Mets E; Van der Meulen J; Van Peer G; Boice M; Mestdagh P; Van de Walle I; Lammens T; Goossens S; De Moerloose B; Benoit Y; Van Roy N; Clappier E; Poppe B; Vandesompele J; Wendel HG; Taghon T; Rondou P; Soulier J; Van Vlierberghe P; Speleman F
Leukemia; 2015 Apr; 29(4):798-806. PubMed ID: 25231743
[TBL] [Abstract][Full Text] [Related]
13. A pre-existing population of ZEB2
Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
[TBL] [Abstract][Full Text] [Related]
14. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
[TBL] [Abstract][Full Text] [Related]
15. New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia.
Paganelli F; Lonetti A; Anselmi L; Martelli AM; Evangelisti C; Chiarini F
Adv Biol Regul; 2019 Dec; 74():100649. PubMed ID: 31523031
[TBL] [Abstract][Full Text] [Related]
16. ZEB2, the Mowat-Wilson Syndrome Transcription Factor: Confirmations, Novel Functions, and Continuing Surprises.
Birkhoff JC; Huylebroeck D; Conidi A
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356053
[TBL] [Abstract][Full Text] [Related]
17. Zeb2 Regulates Myogenic Differentiation in Pluripotent Stem Cells.
Di Filippo ES; Costamagna D; Giacomazzi G; Cortés-Calabuig Á; Stryjewska A; Huylebroeck D; Fulle S; Sampaolesi M
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260521
[TBL] [Abstract][Full Text] [Related]
18. PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis.
Garcia EG; Veloso A; Oliveira ML; Allen JR; Loontiens S; Brunson D; Do D; Yan C; Morris R; Iyer S; Garcia SP; Iftimia N; Van Loocke W; Matthijssens F; McCarthy K; Barata JT; Speleman F; Taghon T; Gutierrez A; Van Vlierberghe P; Haas W; Blackburn JS; Langenau DM
Leukemia; 2021 Mar; 35(3):679-690. PubMed ID: 32606318
[TBL] [Abstract][Full Text] [Related]
19. Novel t(2;12)(q31;p13) in a case of pediatric T-cell acute lymphoblastic leukemia.
Parihar M; Gupta A; Remani AS; Bhattacharyya A; Mishra DK; Chandy M
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e313-5. PubMed ID: 24577543
[TBL] [Abstract][Full Text] [Related]
20. Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32).
Torkildsen S; Gorunova L; Beiske K; Tjønnfjord GE; Heim S; Panagopoulos I
PLoS One; 2015; 10(7):e0132736. PubMed ID: 26186352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
